Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin informs us about “walking pneumonia”, the phase of the polio supplemental immunization campaign in Gaza, mpox circulation, the Marburg virus outbreak in Rwanda, the beginning of influenza season, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, contrasting public health concerns between the US and the UK, if mRNA boosters affect mucosal immunity against SARS-CoV-2 infection, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, if antiviral therapy prevents long COVID and viral sequalae in healthy young marines.

Subscribe (free): Apple Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Mycoplasma pneumoniae infections increasing (CDC)
• Polio vaccination campaign restarts (Reuters)
• North Gaza polio campaign postponed (Reuters)
• 1St clade 1b mpox in UK (GOV.UK)
• UK imports mpox (CIDRAP)
• Clinical trial of MVA-BN for children (Bavarian-Nordic)
• How to stop Marburg virus (Rwanda Biomedical Centre)
• Marburg Virus fact sheet (Rwanda Biomedical Centre)
• Laboratory confirmed influenza associated hospitalizations 2010-2023 (CDC)
• Influenza weekly surveillance report: cliff notes (CDC FluView)
• Mucosal nirsevimab levels in breakthrough bronchiolitis (LANCET Infectious Diseases)
• RSV NETwork (CDC RSV)
• Respiratory virus activity (CDC Respiratory Illnesses)
• COVID-19 deaths (CDC)
• COVID-19 national and regional trends (CDC)
• Waste water scan for 11 pathogens (WastewaterSCan)
• UK public health data tracker (UKHSA)
• COVID-19 variant tracker (CDC)
• SARS-CoV-2 genomes galore (Nextstrain)
• Repeat COVID-19 mRNA vaccination